Navigation Links
Agent Orange Tied to Lethal Prostate Cancer
Date:5/13/2013

MONDAY, May 13 (HealthDay News) -- A link exists between exposure to Agent Orange and deadly forms of prostate cancer in U.S. veterans, according to a new study.

Agent Orange was a chemical spray that was heavily used during the Vietnam War era. It was often contaminated with dioxin, a potentially cancer-causing chemical. Previous research suggests that exposure to Agent Orange increases the risk of prostate cancer, but it wasn't known if it specifically increases the risk of more dangerous forms of the disease.

In this study, researchers looked at more than 2,700 U.S. veterans who underwent a prostate biopsy. Prostate cancer was diagnosed in 33 percent of the veterans, including 17 percent with high-grade disease, according to the study, which was published online May 13 in the journal Cancer.

Exposure to Agent Orange was linked with a 52 percent increase in overall prostate cancer risk, a 75 percent increased risk of high-grade prostate cancer and a more than doubled risk of the deadliest forms of the disease.

The findings suggest that determining veterans' exposure to Agent Orange can help identify those who may be at increased risk for prostate cancer, leading to earlier detection and treatment, said Dr. Mark Garzotto, of the Portland Veterans Administration Medical Center and Oregon Health & Science University, and colleagues.

"It also should raise awareness about potential harms of chemical contaminants in biologic agents used in warfare and the risks associated with waste handling and other chemical processes that generate dioxin or dioxin-related compounds," Garzotto said in a journal news release.

More information

The U.S. National Cancer Institute has more about prostate cancer.

-- Robert Preidt

SOURCE: Cancer, news release, May 13, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pig stomach mucins are effective as anti-viral agents for consumer products
2. Imaging agents predict breast cancer response to endocrine therapy
3. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
4. New substances 15,000 times more effective in destroying chemical warfare agents
5. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
6. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
7. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
8. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
9. Rilpivirine for HIV: Added benefit for single agent proven
10. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
11. Investigational agent targets gene signaling pathways to improve response for patients with CLL
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Agent Orange Tied to Lethal Prostate Cancer
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: